Publications & Works

Publication Network
Articles 24
All (24)
SCI-E, SSCI, AHCI (16)
SCI-E, SSCI, AHCI, ESCI (20)
ESCI (4)
Scopus (19)
TRDizin (7)
Other Publications (1)

1. Electrophysiological, biochemical, and histopathological evidence of thymoquinone-mediated protection in cisplatin-induced cardiotoxicity

Özhan O., Yalcin H. S., Çolak M. C., Ulutaş Z., Yıldız A., Tunc S., et al.
SCIENTIFIC REPORTS , pp.1-27, 2026 (SCI-Expanded, Scopus)

2. Electro-Mechanical Cardiac Remodeling in Metabolic Syndrome: Association Between Frontal QRS-T Angle and Subclinical Left Ventricular Dysfunction Assessed by Four-Dimensional Echocardiography

ULUTAŞ Z., Yigit Y., Karaagac M., CANSEL M.
Journal of Clinical Medicine , vol.15, no.13, 2026 (SCI-Expanded, Scopus)

3. Cardiovascular Protection with Sulfasalazine During Doxorubicin Challenge: Evidence from Oxidative and Histologic Endpoints

Özhan O., Kaya E., Taşolar M. H., Balkar M. E., Yıldız A., Doğru F., et al.
BIOMOLECULES , vol.16, no.8, pp.1-18, 2026 (SCI-Expanded, Scopus)

4. Three- and Nine-Month Follow-Up of Patients with COVID-19: Clinical, Functional, and Radiological Outcomes

Değer M., Kılıç T., Ulutaş Z., Tan M. S., Ödümlü H., Atila A., et al.
Journal of Clinical Medicine , vol.15, no.13, 2026 (SCI-Expanded, Scopus)

5. Rationale and Design of the Türkiye Heart Failure (TURK-HF) Registry

Kocabas U., MURAT S., Kıvrak T., Murat B., Altın C., Yıldız C., et al.
Clinical Cardiology , vol.49, no.5, 2026 (SCI-Expanded, Scopus)

6. ChatGPT response consistency to the 2025 ESC/EACTS guidelines for the management of valvular heart disease: A test–retest study using binary and multiple-choice questions

Mirzaoğlu Ç., ULUTAŞ Z., Karaca Y.
Digital Health , vol.12, 2026 (SCI-Expanded, SSCI, Scopus)

7. Comparison of cilomilast, tadalafil, and both drug combinations in the treatment of monocrotaline-induced pulmonary arterial hypertension in rats

ERMİŞ N., ÖZHAN O., YILDIZ A., ULUTAŞ Z., PARLAKPINAR H., ULU A., et al.
BMC Cardiovascular Disorders , vol.25, no.1, 2025 (SCI-Expanded, Scopus)

8. Curcumin Alleviates Doxorubicin-Induced Cardiotoxicity by Modulating Apelin Expression

Akça B., Dişli O. M., Erdil N., Çiğremiş Y., Özen H., Durhan M., et al.
BIOMOLECULES , vol.15, no.1416, pp.1, 2025 (SCI-Expanded, Scopus)

9. Effects of CAPE on biochemical, histopathological and cardiac parameters in doxorubicin induced cardiotoxicity

DİŞLİ O. M., AKÇA B., ERDİL N., ÖZHAN O., DURHAN M., YILDIZ A., et al.
NORTHERN CLINICS OF ISTANBUL = ISTANBUL KUZEY KLINIKLERI , vol.12, no.5, pp.587-596, 2025 (ESCI, Scopus, TRDizin)

10. Evaluation of right ventricular function in patients with Behcet's disease by four-dimensional echocardiography.

Ulutas Z., Tasolar H., Karaagac M., Hidayet S., Karaca Y., Bayramoglu A., et al.
Echocardiography (Mount Kisco, N.Y.) , vol.41, no.9, 2024 (SCI-Expanded, Scopus)

11. The protective and therapeutic effects of agmatine on isoproterenol-induced myocardial injury in rats

Ulutaş Z., Tapsız S., Özhan O., Sarıhan M. E., Yıldız A., Durhan M., et al.
Medicine Science , vol.12, 2023 (TRDizin)

12. Angiotensin II type 2 receptor agonist treatment of doxorubicin induced heart failure.

Ermis N., Ulutas Z., Ozhan O., Yildiz A., Vardi N., Colak C., et al.
Biotechnic & histochemistry : official publication of the Biological Stain Commission , vol.98, no.5, pp.326-335, 2023 (SCI-Expanded, Scopus)

13. The protective effects of glycyrrhizin on doxorubicin-induced cardiotoxicity in rats

Ulutaş Z., Alıcı M., Ozhan O., Colak M. C., Yıldız A., Arslan A. K., et al.
Annals of Medical Research , vol.30, no.10, pp.1276-1282, 2023 (TRDizin)

14. The importance of pulmonary pulse transit time in indicating right ventricular dysfunction and pulmonary arterial stiffness in rheumatoid arthritis.

Ulutas Z., Tasolar H., Bayramoglu A., Yigit Y., Kuloglu H. E., Karaca Y., et al.
Journal of clinical ultrasound : JCU , vol.51, no.8, pp.1321-1328, 2023 (SCI-Expanded, Scopus)

15. The protective effect of naringenin on ciprofloxacin-induced cardiovascular toxicity in rats

Ulutaş Z., Kurutkan S., Özhan O., Yıldız A., Ulu A., Şahin Büyükkorkmaz L., et al.
ScopeMed , vol.4, 2023 (Peer-Reviewed Journal)

16. Effects of mirtazapine on cisplatin cardiotoxicity in rats

ÖZHAN O., ULUTAŞ Z., Serduman S., ŞAHİN BÜYÜKKORKMAZ L., YILDIZ A., ULU A., et al.
Medicine Science , vol.12, no.2, pp.579-586, 2023 (TRDizin)

17. Evaluation of the Effect of Transcatheter Aortic Valve Implantation on Left Ventricular Function by 4-Dimensional Echocardiography

Bayramoğlu A., ULUTAŞ Z., AKAYCAN J., HİDAYET S., TASOLAR H., CANSEL M., et al.
Türk Kardiyoloji Derneği Arşivi , vol.51, no.3, pp.182-187, 2023 (ESCI, Scopus, TRDizin) Creative Commons License

18. Evaluation of pulmonary artery stiffness and right ventricle functions in polycythemia vera patients by transthoracic echocardiography.

Karaca Y., Hidayet Ş., Bayramoğlu A., Yıldırım E., Berber İ., Güven F., et al.
Echocardiography (Mount Kisco, N.Y.) , vol.40, no.3, pp.196-203, 2023 (SCI-Expanded, Scopus)

19. Successful Bronchial Artery Embolization after Stabilization with Nitric Oxide for the Treatment of Haemoptysis in a Patient with Eisenmenger Syndrome

ULUTAŞ Z., KULOĞLU H. E., KUTLU R., ERMİŞ N.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , vol.50, no.6, pp.459-462, 2022 (ESCI, Scopus, TRDizin)

20. FragmentedQRScomplexes are associated with subclinical left ventricular dysfunction in patients with Behcet's disease:Four-dimensionalspeckle tracking echocardiography

HİDAYET Ş., Yagmur J., BAYRAMOĞLU A., CANSEL M., ERMİŞ N., Tasolar H., et al.
JOURNAL OF CLINICAL ULTRASOUND , vol.49, no.3, pp.227-233, 2021 (SCI-Expanded, Scopus)

21. The Protective Effects of Compound 21 and Valsartan in Isoproterenol-Induced Myocardial Injury in Rats

Ulutas Z., Ermis N., Ozhan O., Parlakpinar H., Vardi N., Ates B., et al.
CARDIOVASCULAR TOXICOLOGY , vol.21, no.1, pp.17-28, 2021 (SCI-Expanded, Scopus)

22. Subclinical left ventricular dysfunction in Sjogren's syndrome assessed by four-dimensional speckle tracking echocardiography

AKAYCAN J., HİDAYET Ş., BAYRAMOĞLU A., YOLBAŞ S., KARACA Y., Yigit Y., et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES , vol.37, no.11, pp.1803-1808, 2020 (SCI-Expanded, Scopus)

23. Assessment of left atrial volume and function in patients with Sjogren's syndrome using three-dimensional echocardiography

HİDAYET Ş., Yagmur J., Karaca Y., Bayramoglu A., YOLBAŞ S., Hidayet E., et al.
ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES , vol.37, no.5, pp.715-721, 2020 (SCI-Expanded, Scopus)

24. Atrial Fibrillation due to Blunt Cardiac Injury: Case Report

Turgut K., YÜCEL N., OĞUZTÜRK H., Ulutas Z., Afsin A.
JOURNAL OF EMERGENCY MEDICINE CASE REPORTS , vol.9, no.4, pp.77-79, 2018 (ESCI, TRDizin)
Papers Presented at Peer-Reviewed Scientific Conferences 8

1. Investigation of the Therapeutic Effects of α-Lipoic Acid and Ambrisentan in a Monocrotaline-Induced Pulmonary Arterial Hypertension Model in Rats

Ayık S., Hüz M., Ulutaş Z., Balkar M. E., Tanbek K., Sönmez R., et al.
3rd INTERNATIONAL AND 28th NATIONAL PHARMACOLOGY CONGRESS, Antalya, Turkey, 20 - 23 November 2025, (Summary Text)

2. Protective Effects of Molsidomine in Rats with Sepsis Induced by Cecal Ligation and Puncture Method

Köse A., Balkar M. E., Özhan O., Doğru F., Keser Z. B., Ulutaş Z., et al.
3rd INTERNATIONAL AND 28th NATIONAL PHARMACOLOGY CONGRESS, Antalya, Turkey, 20 - 23 November 2025, (Summary Text)

3. Protective Effects of Sulfasalazine in a Doxorubicin-Induced Myocarditis Model in Rats

Kaya E., Taşolar M. H., Balkar M. E., Özhan O., Yıldız A., Doğru F., et al.
3rd INTERNATIONAL AND 28th NATIONAL PHARMACOLOGY CONGRESS, Antalya, Turkey, 20 - 23 November 2025, (Summary Text)

4. Modifiye kardiyotorasik indeksin kardiyak fonksiyonlarla ilişkisinin derin öğrenme yöntemleri ile değerlendirilmesi

TAŞOLAR M. H., GÜRAL Y., DEMİRÖZ TAŞOLAR S., GÜNEN M. A., ULUTAŞ Z., BAYRAMOĞLU A., et al.
1. Endokrin Kardiyovasküler Renal Hastalıklar ve Aciller Kongresi, Girne, Cyprus (Kktc), 2 - 05 June 2022, (Summary Text)

5. hipereozinofilik sendromlu hastada gelişen protez kapak trombozu

ULUTAŞ Z., YAGMUR j., ERDİL N., PEKDEMİR H.
33. turkish cardiolojy congress with international participation, 5 October - 08 January 2017, (Summary Text)

6. The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure

ERMİŞ N., ÖZHAN O., ULUTAŞ KURNAZ Z., VARDI N., ÇOLAK C., PARLAKPINAR H.
ESC Congress 2016, Roma, Italy, 28 - 31 August 2016, pp.1, (Full Text)

7. The effect of angiotensin II type 2 receptor agonist treatment on doxorubicin induced heart failure

ERMİŞ N., ÖZHAN O., ULUTAŞ KURNAZ Z., VARDI N., ÇOLAK C., PARLAKPINAR H.
ESC Congress 2016, Roma, Italy, 28 - 31 August 2016, pp.1, (Full Text)

8. The effect of angiotensin II type 2 receptor agonist C21 treatment on Doxorubicin induced heart failure

ERMİŞ N., ÖZHAN O., ULUTAŞ Z., PARLAKPINAR H.
31st Turkish Cardiology Congress, 22 - 25 October 2015, (Summary Text)
Metrics

Publication

33

Publication (WoS)

20

Publication (Scopus)

19

Citation (WoS)

6

H-Index (WoS)

1

Citation (Scopus)

43

H-Index (Scopus)

4

Citation (Scholar)

13

H-Index (Scholar)

1

Project

8

Thesis Advisory

1

Open Access

2